856 IAC 1-38-1 - Applicability
Authority: IC 25-26-13-4
Affected: IC 25-26-13
Sec. 1.
(a) This rule
establishes the standards and procedures concerning the return of expired
legend drugs by an individual or entity licensed to receive legend drugs to
either of the following:
(1) A drug
manufacturer.
(2) A designated
agent of a drug manufacturer.
(b) This rule does not apply to the
following:
(1) Vaccines that prevent
influenza.
(2) Medicine used for
the treatment of malignant hyperthermia.
(3) Other legend drugs as determined by the
board.
Notes
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.